Market Overview

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Kite Pharma, Inc. to Gilead Sciences, Inc. is Fair to Shareholders

Share:

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Kite Pharma, Inc. ("Kite
Pharma" or the "Company") (NASDAQ:KITE) stock prior
to August 28, 2017
.

You are hereby notified that Levi & Korsinsky, LLP has commenced
an investigation into the fairness of the sale
of Kite Pharma, Inc.
to Gilead Sciences, Inc. (NASDAQ:GILD). The
transaction is valued at approximately $11.9 billion. Under the terms of
the transaction, shareholders of Kite Pharma will receive $180.00 in
cash for each share of Kite Pharma common stock they own. To learn more
about the action and your rights, go to:

http://www.zlkdocs.com/IXYS-Info-Request-Form-ma-6064

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or
by telephone at (212) 363-7500, toll-free: (877) 363-5972. There
is no cost or obligation to you
.

Levi & Korsinsky is a national firm with offices in New York,
Connecticut, California, and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities lawsuits and have recovered hundreds of millions of
dollars for aggrieved shareholders
. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.

View Comments and Join the Discussion!